GLOBAL LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICES MARKET SIZE TO CROSS USD 3 BILLION BY 2025, GROWING AT CAGR OF 36% DURING FORECAST PERIOD

Left Atrial Appendage (LAA) Closure Devices Market Size, Share, & Trends Analysis Report by Product (Endocardial and Epicardial LAA closure), End-users (Hospitals, Specialty Cardiac Centers, and Ambulatory Surgery Centers (ASC)), and Geography (APAC, Europe, North America, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2025

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

213 Pages

icon-table

28 Tables

icon-chart

110 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

8 Companies

icon-market

3 Market Segment

LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICES MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 3 BILLION (2025)
CAGR 36% (2020-2025)
Base Year 2019
Historic Year 2018
Forecast Year 2020-2025
Market Segments Product (Endocardial and Epicardial LAA closure), End-users (Hospitals, Specialty Cardiac Centers, and Ambulatory Surgery Centers (ASC))
Geographic Analysis APAC, Europe, North America, Latin America, and Middle East & Africa
Countries Covered US, Canada, Germany, France, UK, Italy, Spain, Japan, China, India, South Korea, Australia, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, and South Africa

INDUSTRY INSIGHTS

Left atrial appendage (LAA) closure devices market size to reach USD 3 billion by 2025, growing at a CAGR of 36% during the forecast period. The left atrial appendage (LAA) closure devices market growth can be attributed to the growing prevalence of atrial fibrillation (AF) across the globe. The growth in the geriatric population and the increased prevalence of lifestyle-related disorders such as obesity, diabetics, and high blood pressure are contributing to the growth of AF. According to several epidemiological studies, AF is the most common arrhythmia, with an estimated prevalence of 1.5–3% in the general population in developed regions. Approximately 7.6 million people over 65 years of age in Europe suffered from AF in 2016, which is expected to increase by around 89%, reaching 14.4 million by 2060. Hence, the high occurrence of AF across the globe is likely to contribute to the growth of the market.

In addition, frequent development and commercial approvals & launches of innovative next-generation LAA closure devices is another primary factor driving the rising uptake of these devices worldwide. For instance, market leader Boston Scientific received CE Mark approval for its Next Generation WATCHMAN FLX Left Atrial Appendage Closure Device in March 2019.

SNIPPETS 

  • Around 14.4 million aged over 65 years and above in Europe are expected to develop atrial fibrillation by 2060, thereby offering expansion growth and innovation opportunities for the growth  
  • The global left atrial appendage (LAA) closure devices market is likely to witness double-digit growth during the forecast period due to the increasing availability of the latest generation LAA closure devices 
  • The hospital end-user segment is expected to account for $1.6 billion incremental growth due to the large uptake of advanced LAA closure devices in several private and public hospitals across the globe. 
  • North America is likely to observe an incremental growth of over $2.27 billion on account of high penetration and availability of advanced treatment solutions for cardiac diseases in the aging population

LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICES MARKET SEGMENTATION

This research report includes a detailed segmentation by 

  • Product
  • End-user
  • Geography

INSIGHTS BY PRODUCTS

The endocardial LAA closure devices segment accounts for the maximum shares as these devices are safe and effective. Several clinical studies conducted on endocardial devices have displayed encouraging results for the patient population in terms of stroke risk reduction, thereby contributing to the market share of the segment. Endocardial devices involve a lower complication rate (around 8.5%) compared with epicardial devices (25.4%), which is likely to boost the segment growth.

The surgical epicardial LAA closure devices have emerged as an alternative procedure for LAA closures intending to improve efficacy, particularly for the patients that have displayed poor results for the standard endocardial technique. In 2019, the epicardial segment accounted for 17% of the global market share.

INSIGHTS BY END-USER

The hospitals segment is accounted for major share of 55% in 2019. Healthcare professionals in the hospital segment use advanced LAA closure devices, including endocardial and epicardial, to treat AF. The segment is growing at a healthy rate, which is expected to continue during the forecast period. The growth in the aging population and the increasing pool of AF patients are the major factors driving the segment growth.

The specialty cardiac centers (SCC) segment provides exclusive healthcare services to patients with suspected or diagnosed cardiac diseases. These centers are solely dedicated to treating patients suffering from cardiac ailments such as AF. The segment is likely to witness the fastest growth during the forecast period.

The ambulatory specialty center (ASC) segment constitutes a small share of the global left atrial appendage (LAA) closure devices market. These centers are cost-effective and offer quality care with the minimal indirect cost of treatment. The segment is expected to witness significant growth, especially in developed countries.

INSIGHTS BY GEOGRAPHY

North America dominates the global left atrial appendage (LAA) closure devices market share. North America is likely to witness highest CAGR of 38%. The presence of a large disease population, coupled with better treatment options for AF, is the primary factor for the high market share. The US is the major revenue contributor to the North America region and accounted for a share of 98% in 2019.

Germany, France, the UK, Spain, and Italy are the major revenue contributors. The market in Europe is expected to grow at a healthy rate during the forecast period. Western Europe has advanced healthcare services, especially for the implantation of LAA closure devices. The increasing incidence of AF, the rapid adoption of advanced devices, and high healthcare expenditures are driving the growth in Europe.

APAC accounted for the third largest share in 2019. China, Japan, Australia, South Korea, and India are the major revenue contributors in the APAC region. A high disease prevalence population, improvement in healthcare spending, and an increase in awareness for heart diseases, including AF, will fuel the growth of the left atrial appendage (LAA) closure devices market in the region.

INSIGHTS BY VENDORS

The global left atrial appendage (LAA) closure devices market is highly consolidated and is characterized by the presence of a few established players holding a majority of the shares. Vendors are offering several endocardial and epicardial devices and are competing based on factors such as technology, safety features, regulatory approvals, marketing strategies, and distribution channels. Boston Scientific, AtriCure, and Abbott are the key vendors in the market. 

The left atrial appendage (LAA) closure market research report includes in-depth coverage of the industry with growth rates, revenues & forecasts for the following segments:

 Market Segmentation by Product

  • Endocardial LAA Closures
  • Epicardial LAA Closure

By End-user  

  • Hospitals
  • Specialty Cardiac Centers
  • Ambulatory Surgery Centers (ASC)

By Geography

  • Europe
    • Spain
    • Germany
    • Italy
    • France
    • UK
  • North America
    • US
    • Canada
  • APAC
    • South Korea
    • China
    • Japan
    • Australia
    • India
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • MEA
    • Turkey
    • Saudi Arabia
    • South Africa

Frequently Asked Questions

What is the market size and compound annual growth rate of the left atrial appendage (LAA) closure devices market?

Left atrial appendage (LAA) closure devices market size to cross USD 3 billion by 2025, growing at CAGR of 36% during forecast period.

What is the growth of the adult and pediatric segment by 2025?

The specialty cardiac centers (SCC) segment provides exclusive healthcare services to patients with suspected or diagnosed cardiac diseases. These centers are solely dedicated to treating patients suffering from cardiac ailments such as AF. The segment is likely to witness the fastest growth during the forecast period.

Who are the major players in the market and what are their market shares?

The key vendors are: V Boston Scientific, AtriCure, Abbott, Biosense Webster, Lifetech Scientific, SentreHEART

What are the factors influencing the growth of the Endocardial LAA Closure segment during the forecast period?

The hospital end-user segment is expected to account for $1.6 billion incremental growth due to the large uptake of advanced LAA closure devices in several private and public hospitals across the globe.

How is the growing population in the Asia Pacific region impacting the growth of the market?

APAC accounted for the third largest share in 2019. China, Japan, Australia, South Korea, and India are the major revenue contributors in the APAC region.

Download Free Sample

The left atrial appendage (LAA) closure devices market is expected to grow at a staggering CAGR of over 36% during the period 2019–2025.

 The following factors are likely to contribute to the growth of the left atrial appendage closure devices market during the forecast period:

  • Emergence of Advanced Imaging Modalities
  • Increasing Focus on Conducting Clinical Trials on LAA Closure Devices
  • Advent of Hybrid Approach in LAA Closure Technique
  • Transference from Open to MI Surgeries

Base Year:                  2019

Forecast Year:           2020–2025

The study considers the present scenario of the left atrial appendage closure devices market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.

Key Vendors

  • Boston Scientific
    • Business Overview
    • Major Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • AtriCure
  • Abbott

Other Vendors

  • Biosense Webster
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Lifetech Scientific
  • SentreHEART

 Investigational Companies

  • Append Medical
    • Business Overview
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Cardia

Market Segmentation by Product

  • Endocardial LAA Closures
  • Epicardial LAA Closure

Market Segmentation by End-user   

  • Hospitals
  • Specialty Cardiac Centers
  • Ambulatory Surgery Centers (ASC)

Market Segmentation by Geography

  • Europe
    • Spain
    • Germany
    • Italy
    • France
    • UK
  • North America
    • US
    • Canada
  • APAC
    • South Korea
    • China
    • Japan
    • Australia
    • India
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • MEA
    • Turkey
    • Saudi Arabia
    • South Africa

1 Research Methodology
2 Research Objectives
3 Research Process

4 Scope & Coverage

4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusion
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments
4.4.1 Market Segmentation By Product
4.4.2 Market Segmentation By End-User
4.4.3 Market Segmentation By Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance
7 Introduction

7.1 Atrial Fibrillation: Overview
7.1.1 Background
7.1.2 LAA Closure Devices For The Treatment Of AF

8 Market Opportunities & Trends
8.1 Emergence Of Advanced Imaging Modalities
8.2 Vendors Increasing Focus On Conducting Clinical Trials On LAA Closure Devices
8.3 Emergence Of Hybrid Approach In LAA Closure Technique
8.4 Promising Investigational LAA Closure Devices
8.5 Strategic Acquisitions

9 Market Growth Enablers
9.1 Rising Incidence Of AF
9.2 Transference From Open To Mi Surgeries
9.3 Frequent Product Approval
9.4 Significant Long-Term Cost Effectiveness Associated With LAA Closure

10 Market Restraints
10.1 High Use Of Oral Drugs
10.2 Complications Associated With LAA Closure Devices
10.3 Stringent Regulations & Product Recalls

11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat Of New Entrants
11.3.2 Bargaining Power Of Suppliers
11.3.3 Bargaining Power Of Buyers
11.3.4 Threat Of Substitutes
11.3.5 Competitive Rivalry

12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Endocardial LAA Closure
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Epicardial LAA Closure
12.4.1 Market Overview
12.4.2 Market Size & Forecast

13 End-User
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Hospitals
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Specialty Cardiac Centers
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.5 ASCS
13.5.1 Market Overview
13.5.2 Market Size & Forecast

14 Geography
14.1 Market Snapshot & Growth Engine
14.2 Geographic Overview

15 North America
15.1 Market Overview
15.2 Market Size & Forecast
15.3 Key Countries
15.3.1 US: Market Size & Forecast
15.3.2 Canada: Market Size & Forecast

16 Europe
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 Germany: Market Size & Forecast
16.3.2 France: Market Size & Forecast
16.3.3 UK: Market Size & Forecast
16.3.4 Spain: Market Size & Forecast
16.3.5 Italy: Market Size & Forecast

17 APAC
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 China: Market Size & Forecast
17.3.2 Japan: Market Size & Forecast
17.3.3 Australia: Market Size & Forecast
17.3.4 South Korea: Market Size & Forecast
17.3.5 India: Market Size & Forecast

18 Latin America
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Brazil: Market Size & Forecast
18.3.2 Mexico: Market Size & Forecast
18.3.3 Argentina: Market Size & Forecast

19 Middle East & Africa
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Turkey: Market Size & Forecast
19.3.2 Saudi Arabia: Market Size & Forecast
19.3.3 South Africa: Market Size & Forecast

20 Competitive Landscape
20.1 Competition Overview
20.2 Market Share Analysis
20.2.1 Boston Scientific
20.2.2 AtriCure
20.2.3 Abbott

21 Key Company Profiles
21.1 Boston Scientific
21.1.1 Business Overview
21.1.2 Product Offerings
21.1.3 Key Strategies
21.1.4 Key Strengths
21.1.5 Key Opportunities
21.2 AtriCure
21.2.1 Business Overview
21.2.2 Product Offerings
21.2.3 Key Strategies
21.2.4 Key Strengths
21.2.5 Key Opportunities
21.3 Abbott
21.3.1 Business Overview
21.3.2 Product Offerings
21.3.3 Key Strategies
21.3.4 Key Strengths
21.3.5 Key Opportunities

22 Other Prominent Vendors
22.1 Biosense Webster
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 Lifetech Scientific
22.2.1 Business Overview
22.2.2 Product Offerings
22.2.3 Key Strategies
22.2.4 Key Strengths
22.2.5 Key Opportunities
22.3 SentreHEART
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strategies
22.3.4 Key Strengths
22.3.5 Key Opportunities

23 Investigational Companies
23.1 Append Medical
23.1.1 Business Overview
23.1.2 Key Strategies
23.1.3 Key Strengths
23.1.4 Key Opportunities
23.2 Cardia
23.2.1 Business Overview
23.2.2 Key Strategies
23.2.3 Key Strengths
23.2.4 Key Opportunities

24 Report Summary
24.1 Key Takeaways
24.2 Strategic Recommendations

25 Quantitative Summary
25.1 Product
25.2 End-User
25.3 Geography

26 Appendix
26.1 Abbreviations

List Of Exhibits 

Exhibit 1               Segmentation of Global LAA closure devices Market

Exhibit 2               Market Size Calculation Approach 2019

Exhibit 3               Most Common Signs & Symptoms of AF

Exhibit 4               Irregular Heartbeat Associated with AF

Exhibit 5               Overview of the LAA Closure

Exhibit 6               Types of LAA Closure

Exhibit 7               Global LAA Closure Devices Market Snapshot

Exhibit 8               Global LAA Closure Devices Market by Geography 2019 (%)

Exhibit 9               Global LAA Closure Devices Market by Product 2019 (%)

Exhibit 10             Impact of Emergence of Advanced Imaging Modalities

Exhibit 11             Key Advantages of TEE over Cardiac MRI and CT

Exhibit 12             Key Potential Additional Value of 3D TEE vs. 2D TEE

Exhibit 13             Impact of Vendors Increasing Focus on Conducting Clinical Trials on LAA Closure Devices

Exhibit 14             Impact of Emergence of Hybrid Approach in LAA Closure Technique

Exhibit 15             Key Benefits of One-stage Hybrid LAA Closure Procedure

Exhibit 16             Impact of Promising Investigational LAA Closure Devices

Exhibit 17             Impact of Strategic Acquisitions

Exhibit 18             Impact of Rising Incidence of AF

Exhibit 19             Mortality Rate of Atrial Fibrillation among Men in Developing & Developed Countries 1990−2015 (Per 100,000 population)

Exhibit 20             Age-adjusted prevalence of Atrial Fibrillation Among Men & Women in Developing & Developed Countries (Per 100,000 population)

Exhibit 21             Recommended Patients for LAA closure Devices

Exhibit 22             Anticoagulation Use Declines with Increased CHADS2 Score

Exhibit 23             Impact of Transference from Open to MI Surgeries

Exhibit 24             Key Benefits of Using MI LAA Closure Approach

Exhibit 25             Impact of Frequent Product Approval

Exhibit 26             Impact of Significant Long-term Cost Effectiveness Associated with LAA Closure

Exhibit 27             Total Cumulative Cost for LAA Occlusion vs. Warfarin at 1st Year Compared to 10th Year ($)

Exhibit 28             Impact of High Use of Oral Drugs

Exhibit 29             Most Commonly Used OATs

Exhibit 30             Ideal Patient Care Pathway for AF Patients

Exhibit 31             Impact of Complications Associated with LAA Closure Devices

Exhibit 32             Type of Common Complications Associated with Percutaneous LAA Closure

Exhibit 33             Impact of Stringent Regulations & Product Recalls

Exhibit 34             Major Actions/Sanctions Imposed on Manufacturers by Regulatory Bodies

Exhibit 35             Global LAA Closure Devices Market 2019–2025 ($ million)

Exhibit 36             Global LAA Closure Devices Market by Geography

Exhibit 37             Global LAA Closure Devices Market by Product

Exhibit 38             Global LAA Closure Devices Market by End-user

Exhibit 39             Five Forces Analysis 2019

Exhibit 40             Incremental Growth by Product 2019 & 2025

Exhibit 41             Global LAA Closure Devices Market by Product

Exhibit 42             Global LAA Closure Devices Market by Product: Incremental Growth

Exhibit 43             Global LAA Closure Devices Market by Product: Absolute Growth

Exhibit 44             Global Endocardial LAA Closure Devices Market: Incremental & Absolute Growth

Exhibit 45             Global Endocardial LAA Closure Devices Market 2019–2025 ($ million)

Exhibit 46             Global Epicardial LAA Closure Devices Market: Incremental & Absolute Growth

Exhibit 47             Global Epicardial LAA Closure Devices Market 2019–2025 ($ million)

Exhibit 48             Incremental Growth by End-user 2019 & 2025

Exhibit 49             Global LAA Closure Devices Market by End-user

Exhibit 50             Global LAA Closure Devices Market by End-user: Incremental Growth

Exhibit 51             Global LAA Closure Devices Market by End-user: Absolute Growth

Exhibit 52             Global LAA Closure Devices Market by Hospitals: Incremental & Absolute Growth Comparison

Exhibit 53             Global LAA Closure Devices Market by Hospitals 2019–2025 ($ million)

Exhibit 54             Global LAA Closure Devices Market by Specialty Cardiac Centers: Incremental & Absolute Growth Comparison

Exhibit 55             Global LAA Closure Devices Market by Specialty Cardiac Centers 2019–2025 ($ million)

Exhibit 56             Global LAA Closure Devices Market by ASCs: Incremental & Absolute Growth Comparison

Exhibit 57             Global LAA Closure Devices Market by ASCs 2019–2025 ($ million)

Exhibit 58             Incremental Growth by Geography 2019 & 2025

Exhibit 59             Global LAA Closure Devices Market by Geography

Exhibit 60             Global LAA Closure Devices Market by Geography 2019: Key Countries ($ million)

Exhibit 61             Global LAA Closure Devices Market by Geography: Incremental Growth

Exhibit 62             Global LAA Closure Devices Market by Geography: Absolute Growth

Exhibit 63             North America LAA Closure Devices Market in 2019

Exhibit 64             North America LAA Closure Devices Market: Incremental & Absolute Growth Comparison

Exhibit 65             LAA Closure Devices Market in North America 2019–2025 ($ million)

Exhibit 66             Incremental Growth in North America 2019 & 2025

Exhibit 67             LAA Closure Devices Market in US 2019–2025 ($ million)

Exhibit 68             LAA Closure Devices Market in Canada 2019–2025 ($ million)

Exhibit 69             Europe LAA Closure Devices Market in 2019

Exhibit 70             Europe LAA Closure Devices Market: Incremental & Absolute Growth Comparison

Exhibit 71             LAA Closure Devices Market in Europe 2019–2025 ($ million)

Exhibit 72             Incremental Growth in Europe 2019 & 2025

Exhibit 73             LAA Closure Devices Market in Germany 2019–2025 ($ million)

Exhibit 74             LAA Closure Devices Market in France 2019–2025 ($ million)

Exhibit 75             LAA Closure Devices Market in UK 2019–2025 ($ million)

Exhibit 76             LAA Closure Devices Market in Spain 2019–2025 ($ million)

Exhibit 77             LAA Closure Devices Market in Italy 2019–2025 ($ million)

Exhibit 78             APAC LAA Closure Devices Market in 2019

Exhibit 79             APAC LAA Closure Devices Market: Incremental & Absolute Growth Comparison

Exhibit 80             LAA Closure Devices Market in APAC 2019–2025 ($ million)

Exhibit 81             Incremental Growth in APAC 2019 & 2025

Exhibit 82             LAA Closure Devices Market in China 2019–2025 ($ million)

Exhibit 83             LAA Closure Devices Market in Japan 2019–2025 ($ million)

Exhibit 84             LAA Closure Devices Market in Australia 2019–2025 ($ million)

Exhibit 85             LAA Closure Devices Market in South Korea 2019–2025 ($ million)

Exhibit 86             LAA Closure Devices Market in India 2019–2025 ($ million)

Exhibit 87             Latin America LAA Closure Devices Market in 2019

Exhibit 88             Latin America LAA Closure Devices Market: Incremental & Absolute Growth Comparison

Exhibit 89             LAA Closure Devices Market in Latin America 2019–2025 ($ million)

Exhibit 90             Incremental Growth in Latin America 2019 & 2025

Exhibit 91             LAA Closure Devices Market in Brazil 2019–2025 ($ million)

Exhibit 92             LAA Closure Devices Market in Mexico 2019–2025 ($ million)

Exhibit 93             LAA Closure Devices Market in Argentina 2019–2025 ($ million)

Exhibit 94             Middle East & Africa LAA Closure Devices Market in 2019

Exhibit 95             Middle East & Africa LAA Closure Devices Market: Incremental & Absolute Growth Comparison

Exhibit 96             LAA Closure Devices Market in Middle East & Africa 2019–2025 ($ million)

Exhibit 97             Incremental Growth in Middle East & Africa 2019 & 2025

Exhibit 98             LAA Closure Devices Market in Turkey 2019–2025 ($ million)

Exhibit 99             LAA Closure Devices Market in Saudi Arabia 2019–2025 ($ million)

Exhibit 100          LAA Closure Devices Market in South Africa 2019–2025 ($ million)

Exhibit 101          Global LAA Closure Devices Market: Vendors Market Share (2019)

Exhibit 102          Boston Scientific: R&D Expenditure 2017−2019 ($ million)

Exhibit 103          Boston Scientific: Revenue by Segments 2018 & 2019 ($ million)

Exhibit 104          Boston Scientific: Revenue by Geography 2019 (%)

Exhibit 105          AtriCure: R&D Expenditure 2017−2019 ($ million)

Exhibit 106          AtriCure: Revenue by Product Segments 2018 & 2019 ($ million)

Exhibit 107          AtriCure: Revenue by Geography 2019 (%)

Exhibit 108          Abbott Revenue 2017−2019 ($ billion)

Exhibit 109          Abbott Revenue Breakdown by Business Segments 2017−2019 ($ million)

Exhibit 110          Abbott R&D Expenditure 2017−2019 ($ billion)

 

List Of Tables    

Table 1              Key Caveats

Table 2              Currency Conversion 2013−2019

Table 3              Major Clinical Studies Conducted by Vendors on LAA Closure Devices

Table 4               Popular Investigational LAA Closure Devices

Table 5               Major Acquisitions in Global LAA Closure Devices Market

Table 6                List of New Product Approval/Launch

Table 7                Cost benefit of LAAC Compared to Warfarin

Table 8                Some LAA Closure Devices & Associated Complications

Table 9                Recent Product Recalls

Table 10               Key Endocardial LAA Closure Devices

Table 11               Key Epicardial LAA Closure Devices

Table 12               Provincial Reimbursement Policy in China

Table 13               Competitive Structure Analysis of Global Left Atrial Appendage Closure Devices Market

Table 14               Global LAA Closure Devices Market: Vendors Ranking 2019

Table 15               Boston Scientific: Major Product Offerings

Table 16               AtriCure: Major Product Offerings

Table 17               Abbott: Major Product Offerings

Table 18               Biosense Webster: Major Product Offerings

Table 19               Lifetech Scientific: Major Product Offerings

Table 20               SentreHEART: Major Product Offerings

Table 21               Append Medical: Investigational LAA Closure Product Offerings

Table 22               Cardia: Investigational LAA Closure Product Offerings

Table 23               Global LAA Closure Devices Market by Product 2019−2025 ($ million)

Table 24               Global LAA Closure Devices Market by Product 2019−2025 (%)

Table 25               Global LAA Closure Devices Market by End-user 2019−2025 ($ million)

Table 26               Global LAA Closure Devices Market by End-user 2019−2025 (%)

Table 27               Global LAA Closure Devices Market by Geography 2019−2025 ($ million)

Table 28               Global LAA Closure Devices Market by Geography 2019−2025 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date